AGP Picks
View all

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on September 25, 2026

Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner
Comprehensive Ultrasonic Pneumatic Lithotripter Market Report Covers Forecasts, Innovations And Industry Outlook
Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026
Kraig Labs’ Atlas Milestone Opens the Door to Potential Historic Spider Silk Advancements
Knowtex, the First Frontier AI Lab for Healthcare, Named Prime Awardee on VA's Nine-Figure Ambient Scribe Enterprise Contract
CIRM awards $9 million to Enloe Health to bring cell and gene therapies closer to patients in Northern California
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
National Association of Specialty Pharmacy Honors Poster Award Winners and Scholarship Recipients at inSPire2026
Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026
Latest Virtual Rehabilitation Telerehabilitation Systems Market Research,Highlights Future Industry Trends And Forecasts
Vitamin C Gummies Market Trends And Forecast Analysis Reveal Strong Long-Term Potential
Vitamin C Zinc Lozenges Market To Reach $3.49 Billion By 2030 Driven By Expanding Industry Demand
Teladoc Health Announces Chief Legal Officer Transition
CDT Equity Inc. Announces Reverse Stock Split
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
neurocare and Wave Neuroscience partner to expand patient access to FDA-Cleared MeRT® therapy for PTSD on the Apollo TMS Therapy System
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.